Zobrazeno 1 - 10
of 15
pro vyhledávání: '"M. S. Safarova"'
Autor:
O. I. Afanasieva, M. V. Ezhov, M. I. Afanasieva, M. S. Safarova, J. V. Berestetskaya, S. N. Pokrovsky
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 6, Iss 4, Pp 474-480 (2016)
Background. Atherosclerosis is a systemic disease. That is why the damage is not restricted by one vascular area in 18-50% of patients. High serum level of lipoprotein(a) [Lp(a)] is an independent risk factor for coronary, carotid and peripheral athe
Externí odkaz:
https://doaj.org/article/259358e3f1d34e9696fd16244d9de74b
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 9, Iss 5, Pp 564-569 (2015)
Review of large of trials that prove the positive impact of high-dose lipid-lowering therapy on the prognosis in patients with ischemic heart disease (IHD) are presented. The data on the efficacy of the lipid profile correction by lipid apheresis in
Externí odkaz:
https://doaj.org/article/23a65a4ecbe04399bb4d9f313455a908
Autor:
M. V. Ezhov, M. S. Safarova, Yu. G. Matchin, D. I. Soboleva, O. I. Afanasyeva, S. N. Pokrovsky
Publikováno v:
Klinicist, Vol 5, Iss 1, Pp 18-23 (2014)
Objective: to study an association of high lipoprotein(a) [Lp(a)] levels with the development of restenosis and the progression of coronaryatherosclerosis after percutaneous coronary interventions (PCI) in patients with chronic coronary heart disease
Externí odkaz:
https://doaj.org/article/10364533174746df9fcb0c87fbe040e9
Publikováno v:
Медицинский совет, Vol 0, Iss 4-2, Pp 55-61 (2013)
The review presents data on the effectiveness of lipid profile correction with maximum doses of statins, primarily atorvastatin, and lipoprotein apheresis. The results of large-scale studies and meta-analyses evaluating the use of statins before and
Externí odkaz:
https://doaj.org/article/0d0f3aa287b84bdcb0a99851ad3ad4f5
Autor:
O. I. Afanasyeva, M. V. Ezhov, M. S. Safarova, M. I. Afanasyeva, I. Yu. Adamova, S. N. Pokrovsky
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 9, Iss 6, Pp 10-16 (2010)
Aim. To investigate the role of lipoprotein(a) (Lp(a)) and apoprotein (a) (apo(a)) phenotype in pathogenesis of coronary artery (CorA) and carotid artery (CarA) atherosclerosis and its complications in women. Material and methods. The study included
Externí odkaz:
https://doaj.org/article/55e6b6d973f14dd6a86c6107782eaaef
Autor:
M. S. Safarova, M. V. Ezhov, V. P. Lupanov, I. A. Alekseeva, Yu. G. Matchin, V. V. Kukharchuk
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 9, Iss 5, Pp 86-90 (2010)
Externí odkaz:
https://doaj.org/article/dfde505e39244c24af3dd1ad8a849816
Autor:
Y.O. Juraeva, Z.Y. Khalimova, D. U. Uralova, M. S. Safarova, Rsnpmce Named After Y.Kh. Turakulov, Tashkent, Uzbekistan, A. A. Gumarova
Publikováno v:
The American Journal of Medical Sciences and Pharmaceutical Research. :78-86
Hyperprolactinemia syndrome is one of the most common neuroendocrine disorders. In the structure of endocrine pathology, it ranks third after diabetes mellitus and thyroid diseases. The article is devoted to the topical issues of diagnosing hyperprol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39b4e85dffbe2ffa752eab30aeb5af31
https://doi.org/10.37547/tajmspr/volume02issue12-13
https://doi.org/10.37547/tajmspr/volume02issue12-13
Autor:
Olga I. Afanasieva, M.I. Afanasieva, Marat V. Ezhov, M. S. Safarova, J. V. Berestetskaya, S. N. Pokrovsky
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 6, Iss 4, Pp 474-480 (2016)
Background. Atherosclerosis is a systemic disease. That is why the damage is not restricted by one vascular area in 18-50% of patients. High serum level of lipoprotein(a) [Lp(a)] is an independent risk factor for coronary, carotid and peripheral athe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8ba73d2302c66eafa2e77d3ee1385cc
https://www.rpcardio.com/jour/article/view/843
https://www.rpcardio.com/jour/article/view/843
Autor:
M S, Safarova, M V, Ezhov
Publikováno v:
Kardiologiia. 55(4)
Series of experimental, epidemiological, and genetic studies have demonstrated that elevated lipoprotein(a) [Lp(a)] level is associated with cardiovascular disease independently from traditional risk factors of atherosclerosis. This review covers the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::735059b82c856740f407fc12926ca80f
https://pubmed.ncbi.nlm.nih.gov/28294902
https://pubmed.ncbi.nlm.nih.gov/28294902
Autor:
M S, Safarova, M V, Ezhov
Publikováno v:
Kardiologiia. 55(4)
Series of experimental, epidemiological, and genetic studies have demonstrated that elevated lipoprotein(a) [Lp(a)] level is associated with cardiovascular disease independently from traditional risk factors of atherosclerosis. This review covers the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a74bc9f626a3ca404485f53b06e88103
https://pubmed.ncbi.nlm.nih.gov/26502507
https://pubmed.ncbi.nlm.nih.gov/26502507